1. Home
  2. SONN vs EDBL Comparison

SONN vs EDBL Comparison

Compare SONN & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • EDBL
  • Stock Information
  • Founded
  • SONN N/A
  • EDBL 2020
  • Country
  • SONN United States
  • EDBL United States
  • Employees
  • SONN N/A
  • EDBL N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • EDBL Farming/Seeds/Milling
  • Sector
  • SONN Health Care
  • EDBL Consumer Staples
  • Exchange
  • SONN Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • SONN 3.8M
  • EDBL 3.3M
  • IPO Year
  • SONN N/A
  • EDBL 2022
  • Fundamental
  • Price
  • SONN $1.11
  • EDBL $2.71
  • Analyst Decision
  • SONN Strong Buy
  • EDBL
  • Analyst Count
  • SONN 1
  • EDBL 0
  • Target Price
  • SONN $20.00
  • EDBL N/A
  • AVG Volume (30 Days)
  • SONN 46.3K
  • EDBL 450.2K
  • Earning Date
  • SONN 08-13-2025
  • EDBL 08-13-2025
  • Dividend Yield
  • SONN N/A
  • EDBL N/A
  • EPS Growth
  • SONN N/A
  • EDBL N/A
  • EPS
  • SONN N/A
  • EDBL N/A
  • Revenue
  • SONN $1,000,000.00
  • EDBL $13,443,000.00
  • Revenue This Year
  • SONN $5,376.22
  • EDBL $29.56
  • Revenue Next Year
  • SONN N/A
  • EDBL $20.00
  • P/E Ratio
  • SONN N/A
  • EDBL N/A
  • Revenue Growth
  • SONN 978.39
  • EDBL N/A
  • 52 Week Low
  • SONN $1.08
  • EDBL $1.80
  • 52 Week High
  • SONN $10.02
  • EDBL $39.50
  • Technical
  • Relative Strength Index (RSI)
  • SONN 38.81
  • EDBL 46.61
  • Support Level
  • SONN $1.11
  • EDBL $2.53
  • Resistance Level
  • SONN $1.25
  • EDBL $2.82
  • Average True Range (ATR)
  • SONN 0.06
  • EDBL 0.25
  • MACD
  • SONN 0.00
  • EDBL -0.08
  • Stochastic Oscillator
  • SONN 0.00
  • EDBL 21.10

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: